1-Methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazine, 95.0%, 25g

Methyl 5,5-dimethyl-2-oxocyclohexane-1-carboxylate, 95%, 10g

4-Bromo-2-(dimethylamino)pyridine, 95.0%, 5g

(S)-3-((tert-Butoxycarbonyl)amino)-4-(4-iodophenyl)butanoic acid, 98%, 5g

(1S,3aR,4S,7aS)-1-((R)-1-((4-Ethyl-4-hydroxyhexyl)oxy)ethyl)-7a-methyloctahydro-1H-inden-4-ol, 98%, 250mg

4-CHLORO-2-(TRIFLUOROMETHOXY)BENZOIC ACID, 95.0%, 5g

(S)-4-Benzyl-3-(5-bromopentanoyl)oxazolidin-2-one, 98%, 100g

4-Iodobutyl acetate, 98%, 1g

(S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetic acid, 97%, 2.5g

Syringe filters ROTILABO® MCE, 0,22 µm, 50 Piece(s)

ETHYL 5-AMINO-6-BROMOPYRAZINE-2-CARBOXYLATE, 95%, 1g

alpha,alpha'-Bis(4-hydroxy-3,5-dimethylphenyl)-1,4-diisopropylbenzene>98.0%(GC)25g

2-([1,1'-Biphenyl]-4-ylcarbamoyl)benzoic acid, 95.0%, 1g